ANDREW I KOVEN
CIK 1258673 · President & Chief Business Off · last filed 2026-06-08
ANDREW I KOVEN is a President & Chief Business Off who has filed 49 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for NRBO, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $224 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$224
7
49
-$4.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Director | 21,339 | $2.36 | $50.4K | $0 | 6 | 2026-06-08 |
| KALA | Director | 339 | $0.66 | $224 | $0 | 10 | 2025-06-17 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | President & Chief Business Off | 1,183,419 | — | — | -$8.0K | 11 | 2018-06-06 |
| POZEN INC /NC (POZN) Delisted | President, Chief Business Ofc. | 1,476,674 | — | — | $0 | 1 | 2015-06-04 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | EVP, CAO, GC and Secretary | 0 | — | — | -$4.67M | 10 | 2015-01-30 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | EVP & Chief Admin & Legal Ofc | 0 | — | — | $0 | 4 | 2011-05-16 |
| SEPRACOR INC /DE/ (SEPR) Delisted | Exec VP, General Counsel | 81,668 | — | — | $0 | 4 | 2009-10-19 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +17,186 | $0 | EDGAR |
| 2026-03-17 | KALA | Notice (144) | −14,466 | -$3.8K | EDGAR |
| 2025-07-01 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +28,147 | $0 | EDGAR |
| 2025-06-17 | KALA | Grant (A) | +3,050 | $0 | EDGAR |
| 2024-06-12 | KALA | Grant (A) | +1,750 | $0 | EDGAR |
| 2024-06-07 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +5,051 | $0 | EDGAR |
| 2023-07-28 | MetaVia Inc. (NRBO) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2023-06-23 | KALA | Grant (A) | +8,915 | $0 | EDGAR |
| 2023-06-02 | KALA | Mixed | +2,197 | $0 | EDGAR |
| 2022-06-17 | KALA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.